← FDA Drug Approvals (Drugs@FDA)

TACROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2018-04-16

Drug application

FDA Application #

ANDA210393

Application type

Abbreviated New Drug Application (Generic)

Brand name

TACROLIMUS

Generic name

TACROLIMUS

Active ingredients

TACROLIMUS

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2018-04-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown